CN103652891A - Lactobacillus casei embedding microcapsule and preparation method thereof - Google Patents
Lactobacillus casei embedding microcapsule and preparation method thereof Download PDFInfo
- Publication number
- CN103652891A CN103652891A CN201310626099.1A CN201310626099A CN103652891A CN 103652891 A CN103652891 A CN 103652891A CN 201310626099 A CN201310626099 A CN 201310626099A CN 103652891 A CN103652891 A CN 103652891A
- Authority
- CN
- China
- Prior art keywords
- lactobacillus casei
- microcore
- microcapsule
- core
- palm oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 244000199866 Lactobacillus casei Species 0.000 title claims abstract description 105
- 235000013958 Lactobacillus casei Nutrition 0.000 title claims abstract description 104
- 229940017800 lactobacillus casei Drugs 0.000 title claims abstract description 104
- 239000003094 microcapsule Substances 0.000 title claims abstract description 50
- 238000002360 preparation method Methods 0.000 title description 4
- 239000000017 hydrogel Substances 0.000 claims abstract description 22
- 239000011247 coating layer Substances 0.000 claims abstract description 11
- 239000010410 layer Substances 0.000 claims abstract description 11
- 238000004321 preservation Methods 0.000 claims abstract description 11
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 6
- 239000008158 vegetable oil Substances 0.000 claims abstract description 6
- 239000002861 polymer material Substances 0.000 claims abstract description 4
- 229920003169 water-soluble polymer Polymers 0.000 claims abstract description 4
- 235000019482 Palm oil Nutrition 0.000 claims description 27
- 239000002540 palm oil Substances 0.000 claims description 27
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 26
- 239000002245 particle Substances 0.000 claims description 19
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 17
- 235000010413 sodium alginate Nutrition 0.000 claims description 17
- 239000000661 sodium alginate Substances 0.000 claims description 17
- 229940005550 sodium alginate Drugs 0.000 claims description 17
- 239000000243 solution Substances 0.000 claims description 17
- 239000000230 xanthan gum Substances 0.000 claims description 17
- 229920001285 xanthan gum Polymers 0.000 claims description 17
- 229940082509 xanthan gum Drugs 0.000 claims description 17
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 14
- 238000003756 stirring Methods 0.000 claims description 14
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 13
- 239000000839 emulsion Substances 0.000 claims description 13
- 238000010563 solid-state fermentation Methods 0.000 claims description 13
- 235000010493 xanthan gum Nutrition 0.000 claims description 13
- 235000010418 carrageenan Nutrition 0.000 claims description 12
- 239000000679 carrageenan Substances 0.000 claims description 12
- 229920001525 carrageenan Polymers 0.000 claims description 12
- 229940113118 carrageenan Drugs 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 12
- 239000010802 sludge Substances 0.000 claims description 12
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 12
- 239000011259 mixed solution Substances 0.000 claims description 11
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 claims description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 7
- 229940041514 candida albicans extract Drugs 0.000 claims description 7
- 239000004310 lactic acid Substances 0.000 claims description 7
- 235000014655 lactic acid Nutrition 0.000 claims description 7
- 239000012138 yeast extract Substances 0.000 claims description 7
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 6
- 239000008103 glucose Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- 239000000499 gel Substances 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 2
- UEJWRQDKIBEMCR-UHFFFAOYSA-L calcium;sodium;carbonate Chemical compound [Na+].[Ca+2].[O-]C([O-])=O UEJWRQDKIBEMCR-UHFFFAOYSA-L 0.000 claims description 2
- 239000002775 capsule Substances 0.000 claims description 2
- 235000013351 cheese Nutrition 0.000 claims description 2
- 230000008018 melting Effects 0.000 claims description 2
- 238000002844 melting Methods 0.000 claims description 2
- 235000013336 milk Nutrition 0.000 claims description 2
- 239000008267 milk Substances 0.000 claims description 2
- 210000004080 milk Anatomy 0.000 claims description 2
- 241000193830 Bacillus <bacterium> Species 0.000 claims 1
- 239000002202 Polyethylene glycol Substances 0.000 claims 1
- 239000011248 coating agent Substances 0.000 claims 1
- 238000000576 coating method Methods 0.000 claims 1
- 229920001223 polyethylene glycol Polymers 0.000 claims 1
- 238000003860 storage Methods 0.000 abstract description 9
- 239000003814 drug Substances 0.000 abstract description 2
- 238000001035 drying Methods 0.000 abstract description 2
- 235000013305 food Nutrition 0.000 abstract description 2
- 230000004083 survival effect Effects 0.000 abstract description 2
- 239000000203 mixture Substances 0.000 description 15
- 241000894006 Bacteria Species 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 239000000463 material Substances 0.000 description 8
- 229960003563 calcium carbonate Drugs 0.000 description 7
- 235000010216 calcium carbonate Nutrition 0.000 description 7
- 238000005538 encapsulation Methods 0.000 description 7
- 230000000968 intestinal effect Effects 0.000 description 7
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 6
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 6
- 210000004051 gastric juice Anatomy 0.000 description 6
- 229960001031 glucose Drugs 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 239000006041 probiotic Substances 0.000 description 4
- 235000018291 probiotics Nutrition 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 238000001125 extrusion Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000003204 osmotic effect Effects 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 238000007711 solidification Methods 0.000 description 2
- 230000008023 solidification Effects 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 239000001116 FEMA 4028 Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 1
- 229960004853 betadex Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000011162 core material Substances 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 229940014259 gelatin Drugs 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/125—Casei
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Jellies, Jams, And Syrups (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
本发明提供一种包埋干酪乳杆菌的微胶囊,其特征在于:微胶囊为三层包埋的多芯结构,其中,干酪乳杆菌被包埋于第一个水凝胶包被层中形成微芯,在所述的微芯外的第二个包被层为植物油,多个携带植物油包被的微芯被包埋于由水溶性高分子材料形成的第三个包被层中,形成多芯微胶囊。该微胶囊在干燥加工和储藏过程中,能够显著提高干酪乳杆菌的存活率,表现出优良的干酪乳杆菌活菌保藏性能,在食品、医药以及饲料领域具有良好的应用潜力。The invention provides a microcapsule for embedding Lactobacillus casei, which is characterized in that: the microcapsule is a three-layer embedded multi-core structure, wherein Lactobacillus casei is embedded in the first hydrogel coating layer to form The microcore, the second coating layer outside the microcore is vegetable oil, and a plurality of microcores coated with vegetable oil are embedded in the third coating layer formed by water-soluble polymer materials, forming multi-core microcapsules. The microcapsule can significantly improve the survival rate of Lactobacillus casei during drying processing and storage, exhibits excellent preservation performance of live Lactobacillus casei, and has good application potential in the fields of food, medicine and feed.
Description
the
技术领域:Technical field:
本发明涉及的是一种微生物包埋技术,具体涉及的是三大益生菌之一的干酪乳杆菌的多芯微胶囊化包埋技术。 The invention relates to a microorganism embedding technology, in particular to the multi-core microencapsulation embedding technology of Lactobacillus casei, one of the three major probiotics.
背景技术:Background technique:
干酪乳杆菌(Lactobacillus casei)是一种益生菌,能够进入人体后在肠道内大量存活,起到调节肠内菌群平衡、促进人体消化吸收等作用,同时具有高效降血压、降胆固醇,增强人体免疫及预防癌症和抑制肿瘤生长等功能,在食品医药及饲料领域有很好的应用潜力。但是收微胶囊干燥过程中的渗透压增高,以及储存过程中的氧胁迫等因素的影响,干酪乳杆菌极易死亡,需要针对干酪乳杆菌对渗透压敏感和不耐氧胁迫的生理特点,建立阻氧和菌体周围渗透压稳定的微囊化包埋体系,以提高干酪乳杆菌的应用性能。 Lactobacillus casei (Lactobacillus casei) is a kind of probiotics, which can survive in large quantities in the intestinal tract after entering the human body, regulate the balance of intestinal flora, promote digestion and absorption of the human body, etc. Functions such as immunity, cancer prevention and tumor growth inhibition have good application potential in the fields of food, medicine and feed. However, due to the increase of osmotic pressure during the drying process of microcapsules and the influence of factors such as oxygen stress during storage, Lactobacillus casei is very easy to die. A microencapsulated embedding system with oxygen resistance and stable osmotic pressure around the bacteria to improve the application performance of Lactobacillus casei.
经过对现有技术的检索发现,针对干酪乳杆菌类益生菌的微囊化包埋方法和包埋产物,均具有提高益生菌抗逆性的效果。微胶囊的包埋壁材和辅料以海藻酸钠、明胶、羟甲基纤维素、β-环糊精、多孔淀粉、果胶、阿拉伯胶和益生元等为主;胶囊结构类型多为单芯-固芯微胶囊,少数为单芯-液芯微胶囊;部分微胶囊两层或多层包埋,但均为单芯微胶囊,且最外层包埋为油脂或卵磷脂类, After searching the prior art, it is found that the microencapsulation embedding method and embedding products for probiotics of Lactobacillus casei have the effect of improving the stress resistance of probiotics. The embedding wall materials and excipients of microcapsules are mainly sodium alginate, gelatin, hydroxymethyl cellulose, β-cyclodextrin, porous starch, pectin, acacia gum and prebiotics; the capsule structure type is mostly single core -Solid-core microcapsules, a few are single-core-liquid-core microcapsules; some microcapsules are embedded in two or more layers, but all are single-core microcapsules, and the outermost layer is embedded with oil or lecithin,
发明内容。Invention content.
本发明针对干酪乳杆菌不耐氧胁迫和渗透压变化,微囊化包埋和储存过程易死亡的问题,提供一种高活性干酪乳杆菌微囊化包埋方法,有效提高干酪乳杆菌耐热性和储藏性能。 The present invention aims at the problem that Lactobacillus casei is not resistant to oxygen stress and osmotic pressure changes, and is prone to death during microencapsulation embedding and storage, and provides a microencapsulation embedding method with high activity Lactobacillus casei, which can effectively improve the heat resistance of Lactobacillus casei properties and storage properties.
本发明微胶囊为多芯结构,棕榈油脂肪层为中间包被层,以及最外层微胶囊壁材为碳酸钙、海藻酸钠和黄原胶混合物等特征均。 The microcapsule of the present invention has a multi-core structure, the palm oil fat layer is the middle coating layer, and the outermost microcapsule wall material is a mixture of calcium carbonate, sodium alginate and xanthan gum.
一方面,本发明提供一种包埋酪乳杆菌的微胶囊,其特征在于:微胶囊为三层包埋的多芯结构,其中,干酪乳杆菌菌泥或固态发酵产物被包埋于第一水凝胶包被层中形成微芯,在所述的微芯外的第二个包被层为植物油,多个携带植物油包被的微芯被包埋于由水溶性高分子材料形成的第三个包被层中,其中,所述的干酪乳杆菌菌泥或固态发酵产物为保藏号为CCTCC NO:M 2011424的干酪乳杆菌菌株BFT-1所产生。 On the one hand, the present invention provides a microcapsule for embedding Lactobacillus casei, which is characterized in that: the microcapsule is a three-layer embedded multi-core structure, wherein the Lactobacillus casei sludge or solid-state fermentation product is embedded in the first A microcore is formed in the hydrogel coating layer, and the second coating layer outside the microcore is vegetable oil, and a plurality of microcores coated with vegetable oil are embedded in the first water-soluble polymer material. Among the three coating layers, the said Lactobacillus casei sludge or solid-state fermentation product is produced by the Lactobacillus casei strain BFT-1 whose preservation number is CCTCC NO: M 2011424.
优选的,所述的干酪乳杆菌浓度为109~1011cfu/ml。优选的,所述的微芯结构为水凝胶,粒径10~100μm,第二包被层包为融点为24℃的棕榈油层。 Preferably, the concentration of Lactobacillus casei is 10 9 -10 11 cfu/ml. Preferably, the microcore structure is a hydrogel with a particle size of 10-100 μm, and the second coating layer is wrapped with a palm oil layer with a melting point of 24°C.
优选的,本发明设涉及包埋干酪乳杆菌的多芯微胶囊包括:干酪乳杆菌、卡拉胶、斯潘-80、棕榈油、碳酸钙、海藻酸钠和黄原胶,其中:干酪乳杆菌包埋于卡拉胶、葡萄糖、酵母抽提物和乳酸形成的水凝胶微芯中,该微芯进一步包埋于斯潘-80和棕榈油混合物中形成乳浊液,该乳浊液进一步分散于碳酸钙、海藻酸钠和黄原胶混合溶液中,并滴入固化液中形成固化多芯微胶囊。 Preferably, the present invention relates to multi-core microcapsules for embedding Lactobacillus casei including: Lactobacillus casei, carrageenan, Span-80, palm oil, calcium carbonate, sodium alginate and xanthan gum, wherein: Lactobacillus casei Embedded in hydrogel microcores of carrageenan, dextrose, yeast extract, and lactic acid, which are further embedded in a mixture of Span-80 and palm oil to form an emulsion, which is further dispersed In the mixed solution of calcium carbonate, sodium alginate and xanthan gum, and drop into the solidification solution to form solidified multi-core microcapsules.
所述的干酪乳杆菌微芯的粒径分布为10~100μm,所述多芯微胶囊的粒径分布为0.5~5mm。 The particle size distribution of the Lactobacillus casei micro-core is 10-100 μm, and the particle size distribution of the multi-core microcapsule is 0.5-5 mm.
多芯微胶囊中,干酪乳杆菌的包封率为:70~99%。 In the multi-core microcapsules, the encapsulation rate of Lactobacillus casei is 70-99%.
另一方面,本发明涉及上述包埋干酪乳杆菌的多芯微胶囊的制备方法,包括以下步骤: On the other hand, the present invention relates to the preparation method of the above-mentioned multi-core microcapsules of Lactobacillus casei embedded, comprising the following steps:
第一步,制备干酪乳杆菌水凝胶溶液:配制pH为3.5~5.0、卡拉胶质量百分含量为0.1~2%、葡萄糖含量0.1~0.5%、酵母抽提物含量为0.1~0.5%、乳酸浓度为1~5%的混合水溶液,并将温度调节到38~45℃。然后加入干酪乳杆菌菌泥或固态发酵产物,即形成干酪乳杆菌水凝胶溶液。优选的,最合适的温度为40℃,干酪乳杆菌的最佳浓度是8×1010cfu/mL。 The first step is to prepare Lactobacillus casei hydrogel solution: the preparation pH is 3.5-5.0, the mass percentage of carrageenan is 0.1-2%, the content of glucose is 0.1-0.5%, the content of yeast extract is 0.1-0.5%, Lactic acid concentration is 1~5% mixed aqueous solution, and the temperature is adjusted to 38~45°C. Then add Lactobacillus casei sludge or solid-state fermentation product to form Lactobacillus casei hydrogel solution. Preferably, the most suitable temperature is 40°C, and the optimum concentration of Lactobacillus casei is 8×10 10 cfu/mL.
第二步, 制备外层棕榈油包被的干酪乳杆菌水凝胶微芯:将第一步所述干酪乳杆菌水凝胶溶液按体积比1:1~5(最佳的比例为1:3)与相同温度的棕榈油混合,其中棕榈油中包括质量百分比浓度为1~5%的斯潘-80,在1000~2000转/分钟搅拌下形成乳液,然后冷却到25℃,即可形成外层棕榈油包被的干酪乳杆菌水凝胶微芯,结构特征为固态凝胶微芯。 The second step is to prepare the Lactobacillus casei hydrogel microcore coated with palm oil in the outer layer: the Lactobacillus casei hydrogel solution described in the first step is in a volume ratio of 1:1 to 5 (the best ratio is 1: 3) Mix with palm oil at the same temperature, wherein the palm oil includes Span-80 with a mass percentage concentration of 1-5%, form an emulsion under stirring at 1000-2000 rpm, and then cool to 25°C to form The Lactobacillus casei hydrogel microcore coated with palm oil has a structural feature of a solid gel microcore.
第三步,制备包埋干酪乳杆菌微芯的多芯微胶囊:将第二步所述外层棕榈油包被的干酪乳杆菌微芯乳液按体积比1:2~4(最佳的比例为1:3)与碳酸钙-海藻酸钠-黄原胶混合溶液混合均匀(海藻酸钠和黄原胶的质量比为20:1~5、合计质量百分比浓度为1~3%,碳酸钙质量百分比含量为0.5~3%,温度为22~26℃),并滴入温度为0~20℃的1~4%氯化钙溶液中,半小时后形成包埋干酪乳杆菌微芯的固化多芯微胶囊,该胶囊中干酪乳杆菌微芯、棕榈油和海藻酸钠等均为固态结构。 The third step is to prepare multi-core microcapsules embedded with Lactobacillus casei micro-core: the Lactobacillus casei micro-core emulsion coated with the outer palm oil described in the second step is in a volume ratio of 1:2~4 (optimum ratio 1:3) mixed with calcium carbonate-sodium alginate-xanthan gum mixed solution (the mass ratio of sodium alginate and xanthan gum is 20:1~5, the total mass percentage concentration is 1~3%, calcium carbonate The mass percentage content is 0.5~3%, the temperature is 22~26°C), and it is dropped into the 1~4% calcium chloride solution at the temperature of 0~20°C, and after half an hour, the solidification of embedded Lactobacillus casei microcores is formed. Multi-core microcapsules, in which Lactobacillus casei microcores, palm oil and sodium alginate are all solid structures.
本发明所有的百分比含量,没有特备指明,都属于质量百分比含量。 All percentages in the present invention, unless otherwise specified, belong to mass percentages.
本发明通过调节卡拉胶、斯潘-80、碳酸钙、棕榈油、海藻酸钠和黄原胶的浓度和比例来调节干酪乳杆菌微芯的粒径分布、干酪乳杆菌的包封率、干酪乳杆菌存活率以及成品多芯微胶囊的粒径分布,以满足多种应用需求。例如,通过升高卡拉胶的浓度可获得粒径较大的干酪乳杆菌微芯,反之获得粒径较小的微芯,卡拉胶浓度与微芯粒径呈负相关关系;通过提高棕榈油与干酪乳杆菌水凝胶溶液的体积比可得到较高干酪乳杆菌包封率,反之包封率降低,棕榈油与干酪乳杆菌水凝胶体积比与包封率呈负相关关系;通过调整挤出孔径大小可以调节最终多芯微胶囊尺寸,挤出孔径越小粒径越小,挤出孔径越大粒径越大,挤出孔径大小与多芯微胶囊大小呈正相关。 The present invention adjusts the particle size distribution of the Lactobacillus casei microcore, the encapsulation efficiency of the Lactobacillus casei, and the Lactobacillus survival rate and particle size distribution of finished multi-core microcapsules to meet various application requirements. For example, by increasing the concentration of carrageenan, Lactobacillus casei microcores with larger particle sizes can be obtained, and vice versa, microcores with smaller particle sizes are obtained, and the concentration of carrageenan is negatively correlated with the particle size of microcores; The volume ratio of Lactobacillus casei hydrogel solution can obtain higher encapsulation efficiency of Lactobacillus casei, otherwise the encapsulation efficiency decreases, and the volume ratio of palm oil and Lactobacillus casei hydrogel has a negative correlation with the encapsulation efficiency; The size of the exit pore can adjust the size of the final multi-core microcapsule. The smaller the extrusion pore size, the smaller the particle size, and the larger the extrusion pore size, the larger the particle size. The extrusion pore size is positively correlated with the size of the multi-core microcapsule.
本发明所制备包埋干酪乳杆菌的多芯微胶囊中干酪乳杆菌含量为109~1011cfu/ mL,在85℃下加热处理3分钟,剩余活菌数107~1010cfu/ mL;25℃下密封储存60天,剩余活菌数108~1010cfu/ mL;人工模拟胃液下4小时,干酪乳杆菌释放量不高于20%;人工模拟肠液下4小时,干酪乳杆菌释放量不低于90%。与传统产品相比,耐热性和储存性能提高显著,过胃肠溶性能优异。 The content of Lactobacillus casei in the multi-core microcapsules embedded with Lactobacillus casei prepared by the present invention is 10 9 to 10 11 cfu/mL, and after heat treatment at 85°C for 3 minutes, the number of remaining viable bacteria is 10 7 to 10 10 cfu/mL ; Sealed storage at 25°C for 60 days, the number of remaining viable bacteria is 10 8 ~ 10 10 cfu/mL; 4 hours in artificially simulated gastric juice, the release of Lactobacillus casei is not higher than 20%; 4 hours in artificially simulated intestinal juice, Lactobacillus casei The release amount is not less than 90%. Compared with traditional products, the heat resistance and storage performance are significantly improved, and the performance of gastrointestinal dissolution is excellent.
有益效果Beneficial effect
本发明制备操作简单,所得微胶囊无粘连,成球性好,表面圆整,在人工模拟胃液下释放缓慢释放量较低,在人工模拟肠液下可快速大量释放干酪乳杆菌,有利于干酪乳杆菌在动物肠道中的定点释放和发挥功效。 The preparation and operation of the present invention are simple, and the obtained microcapsules have no adhesion, good spheroidity, rounded surface, slow release under artificially simulated gastric juice, and low release amount, and can quickly and massively release Lactobacillus casei under artificially simulated intestinal juice, which is beneficial to cheese milk Targeted release and efficacy of bacilli in the animal gut.
附图说明 Description of drawings
图1为微胶囊外观和内部微芯结构照片图,其中。A、B、C和D顺次为实施例1、2、3和4的微胶囊外观和内部微芯结构照片(上排为外观,下排为对应的内部结构)。 Fig. 1 is a microcapsule appearance and a photogram of the internal microcore structure, wherein. A, B, C and D are photos of the microcapsule appearance and internal microcore structure of Examples 1, 2, 3 and 4 in sequence (the upper row is the appearance, and the lower row is the corresponding internal structure).
干酪乳杆菌BFT-1,分类命名:干酪乳杆菌BFT-1,拉丁学名:Lactobacillus casei BFT-1,保藏号:CCTCC NO:M 2011424,保藏日期为2011年11月25日,保藏单位为:中国典型培养物保藏中心,地址:中国.武汉.武汉大学,邮编:430072。 Lactobacillus casei BFT-1, classification name: Lactobacillus casei BFT-1, Latin scientific name: Lactobacillus casei BFT-1, preservation number: CCTCC NO: M 2011424, preservation date is November 25, 2011, preservation unit is: China Typical Culture Collection Center, address: Wuhan University, Wuhan, China, zip code: 430072.
具体实施方式 Detailed ways
下面对本发明的实施例作详细说明,本实施例在以本发明技术方案为前提下进行实施,给出了详细的实施方式和具体的操作过程,但本发明的保护范围不限于下述的实施例。 The embodiments of the present invention are described in detail below. This embodiment is implemented on the premise of the technical solution of the present invention, and detailed implementation methods and specific operating procedures are provided, but the protection scope of the present invention is not limited to the following implementation example.
以下实施例的涉及包埋干酪乳杆菌的多芯微胶囊包括:干酪乳杆菌BFT-1 (Lactobacillus casei BFT-1 )(保藏号:CCTCC NO:M2011424,保藏日期为2011年11月25日,保藏单位为中国典型培养物保藏中心,地址:中国.武汉.武汉大学)、干酪乳杆菌水凝胶微芯、棕榈油、海藻酸钠和黄原胶微胶囊壁,其中:干酪乳杆菌包埋于水凝胶微芯中,并进一步依次被棕榈油和海藻酸钠-黄原胶包被于外部,最终形成包埋干酪乳杆菌的多芯微胶囊。 The multi-core microcapsules related to embedding Lactobacillus casei of the following examples include: Lactobacillus casei BFT-1 ( Lactobacillus casei BFT-1) (preservation number: CCTCC NO: M2011424, preservation date is November 25, 2011, preservation The unit is China Typical Culture Collection Center, address: China. Wuhan. Wuhan University), Lactobacillus casei hydrogel micro-core, palm oil, sodium alginate and xanthan gum microcapsule wall, in which: Lactobacillus casei is embedded in The hydrogel micro-core is further coated on the outside by palm oil and sodium alginate-xanthan gum in turn, finally forming a multi-core microcapsule embedding Lactobacillus casei.
在下列所有实施例子中的干酪乳杆菌菌泥或干酪乳杆菌固态发酵物料由保藏号为CCTCC No:M2011424的干酪乳杆菌菌株BFT-1所产生。 The Lactobacillus casei sludge or the Lactobacillus casei solid-state fermentation material in all the following examples is produced by the Lactobacillus casei strain BFT-1 with the preservation number of CCTCC No: M2011424.
实施例1Example 1
步骤1:将0.1g卡拉胶悬浮于100mL蒸馏水中,加热溶解后加入0.1g葡萄糖、0.1g酵母抽提物和1.0g乳酸,以氢氧化钠调节pH为3.5,并冷却到38℃。 Step 1: Suspend 0.1g of carrageenan in 100mL of distilled water, heat to dissolve, add 0.1g of glucose, 0.1g of yeast extract and 1.0g of lactic acid, adjust the pH to 3.5 with sodium hydroxide, and cool to 38°C.
步骤2:然后在步骤1形成的溶液中加入干酪乳杆菌菌泥或干酪乳杆菌固态发酵物料,并混合均匀(混合液中干酪乳杆菌浓度为6.3×109cfu/mL)。 Step 2: Then add Lactobacillus casei sludge or Lactobacillus casei solid-state fermentation material to the solution formed in Step 1, and mix evenly (the concentration of Lactobacillus casei in the mixed solution is 6.3×10 9 cfu/mL).
步骤3:将步骤2获得的上述混合溶液与100mL温度为38℃的棕榈油混合,其中棕榈油中包括质量百分比含量为1%的斯潘-80,并在1000转/分钟搅拌速度下搅拌至温度下降到25℃时继续搅拌30min,此时即获得干酪乳杆菌水凝胶微芯乳液,微芯的平均粒径为93.2μm。 Step 3: Mix the above mixed solution obtained in step 2 with 100mL of palm oil at a temperature of 38°C, wherein the palm oil includes 1% Span-80 by mass percentage, and stir at a stirring speed of 1000 rpm to When the temperature dropped to 25° C., the stirring was continued for 30 minutes, at which point the Lactobacillus casei hydrogel micro-core emulsion was obtained, and the average particle diameter of the micro-core was 93.2 μm.
步骤4:进一步将步骤3形成的上述200mL微芯乳液与400mL碳酸钙、海藻酸钠和黄原胶溶液混合均匀(海藻酸钠与黄原胶质量比为20:1、合计质量百分比浓度为1%,碳酸钙质量百分比为0.5%,温度为22℃),然后,挤出到温度为0℃的1%氯化钙溶液中,形成粒径约0.5mm的固化多芯微胶囊(图1,A)。 Step 4: Further mix the above-mentioned 200mL microcore emulsion formed in step 3 with 400mL calcium carbonate, sodium alginate and xanthan gum solution (the mass ratio of sodium alginate to xanthan gum is 20:1, and the total mass percentage concentration is 1 %, the mass percentage of calcium carbonate is 0.5%, and the temperature is 22°C), and then extruded into a 1% calcium chloride solution at 0°C to form solidified multi-core microcapsules with a particle size of about 0.5mm (Figure 1, A).
该微胶囊无粘连、成球性好、表面圆整,干酪乳杆菌菌数为1×109cfu/mL,包封率为71.3%;在85℃下加热处理3分钟,剩余活菌数为2.5×107cfu/mL,未包埋干酪乳杆菌菌泥或固态发酵物料在1000倍稀释下,未检测到活菌;在25℃下密封储存60天,剩余活菌数为4.1×108cfu/mL;在人工模拟胃液下4小时,干酪乳杆菌释放量为19.8%,人工模拟肠液下4小时,干酪乳杆菌释放量为95.7%。 The microcapsules have no adhesion, good spheroidity, and rounded surface. The number of Lactobacillus casei is 1×10 9 cfu/mL, and the encapsulation efficiency is 71.3%. After heat treatment at 85°C for 3 minutes, the number of remaining viable bacteria is 2.5×10 7 cfu/mL, unembedded Lactobacillus casei sludge or solid-state fermentation material was diluted 1000 times, no viable bacteria were detected; when stored in a sealed container at 25°C for 60 days, the remaining viable bacteria were 4.1×10 8 cfu/mL; 4 hours under artificial simulated gastric juice, the release amount of Lactobacillus casei was 19.8%, and under artificial simulated intestinal juice for 4 hours, the release amount of Lactobacillus casei was 95.7%.
实施例2Example 2
步骤1:将2g卡拉胶悬浮于100mL蒸馏水中,加热溶解后加入0.5g葡萄糖、0.5g酵母抽提物和5.0g乳酸,以氢氧化钠调节pH为5.0,并冷却到45℃。 Step 1: Suspend 2g of carrageenan in 100mL of distilled water, heat to dissolve, add 0.5g of glucose, 0.5g of yeast extract and 5.0g of lactic acid, adjust the pH to 5.0 with sodium hydroxide, and cool to 45°C.
步骤2:在步骤1形成的溶液中加入干酪乳杆菌菌泥或干酪乳杆菌固态发酵物料,并混合均匀(混合液中干酪乳杆菌浓为3.5×1012cfu/mL)。 Step 2: Add Lactobacillus casei sludge or Lactobacillus casei solid-state fermentation material to the solution formed in Step 1, and mix evenly (the concentration of Lactobacillus casei in the mixed solution is 3.5×10 12 cfu/mL).
步骤3:将步骤2中形成的上述混合溶液与500mL温度为45℃的棕榈油混合,其中棕榈油中包括质量百分比含量为5%的斯潘-80,并在2000转/分钟搅拌速度下搅拌至温度下降到35℃时继续搅拌30分钟,此时即获得干酪乳杆菌水凝胶微芯乳液,微芯的平均粒径为10.4μm。 Step 3: Mix the above mixed solution formed in step 2 with 500mL of palm oil at a temperature of 45°C, wherein the palm oil includes 5% Span-80 by mass percentage, and stir at a stirring speed of 2000 rpm Stirring was continued for 30 minutes until the temperature dropped to 35° C., at which point a Lactobacillus casei hydrogel micro-core emulsion was obtained, and the average particle diameter of the micro-core was 10.4 μm.
步骤4:进一步将步骤3形成的上述600mL微芯乳液与2400mL碳酸钙、海藻酸钠和黄原胶溶液混合均匀(海藻酸钠与黄原胶质量比为20:5、合计质量百分比浓度为3%,碳酸钙质量百分比浓度为3%,温度为26℃),并挤出到温度为20℃的4%氯化钙溶液中,形成粒径约5mm的固化多芯微胶囊(图1,B)。 Step 4: Further mix the above-mentioned 600mL microcore emulsion formed in step 3 with 2400mL calcium carbonate, sodium alginate and xanthan gum solution (the mass ratio of sodium alginate to xanthan gum is 20:5, and the total mass percentage concentration is 3 %, the mass percentage of calcium carbonate is 3%, the temperature is 26°C), and extruded into a 4% calcium chloride solution at a temperature of 20°C to form solidified multi-core microcapsules with a particle size of about 5 mm (Fig. 1, B ).
该微胶囊无粘连、成球性好、表面圆整,干酪乳杆菌菌数为1×1011cfu/mL,包封率为99.1%;在85℃下加热处理3分钟,剩余活菌数为1.2×1010cfu/mL;在25℃下密封储存60天,剩余活菌数为4.8×1010cfu/mL;在人工模拟胃液下4小时,干酪乳杆菌释放量为12.5%,人工模拟肠液下4小时,干酪乳杆菌释放量为90.5%。 The microcapsules have no adhesion, good spheroidity, and rounded surface. The number of Lactobacillus casei is 1×10 11 cfu/mL, and the encapsulation efficiency is 99.1%. After heat treatment at 85°C for 3 minutes, the number of remaining viable bacteria is 1.2×10 10 cfu/mL; sealed storage at 25°C for 60 days, the number of remaining viable bacteria is 4.8×10 10 cfu/mL; 4 hours under artificial simulated gastric juice, the release of Lactobacillus casei is 12.5%, artificial simulated intestinal juice After 4 hours, the release amount of Lactobacillus casei was 90.5%.
实施例3Example 3
步骤1:将1g卡拉胶悬浮于100mL蒸馏水中,加热溶解后加入0.25g葡萄糖和0.25g酵母抽提物和2.5g乳酸,以氢氧化钠调节pH为4.2,并冷却到41.5℃。 Step 1: Suspend 1g of carrageenan in 100mL of distilled water, heat to dissolve, add 0.25g of glucose, 0.25g of yeast extract and 2.5g of lactic acid, adjust the pH to 4.2 with sodium hydroxide, and cool to 41.5°C.
步骤2:然后在步骤1形成的溶液中加入干酪乳杆菌菌泥或干酪乳杆菌固态发酵物料,并混合均匀(混合液中干酪乳杆菌浓度为1.5×1011cfu/mL)。 Step 2: Then add Lactobacillus casei sludge or Lactobacillus casei solid-state fermentation material to the solution formed in step 1, and mix evenly (the concentration of Lactobacillus casei in the mixed solution is 1.5×10 11 cfu/mL).
步骤3:将上述混合溶液与250mL温度为41.5℃的棕榈油混合,其中棕榈油中包括质量百分比含量为2.5%的斯潘-80,并在1500转/分钟搅拌速度下搅拌至温度下降到25℃时继续搅拌30分钟,此时即获得干酪乳杆菌水凝胶微芯乳液,微芯的平均粒径为53.8μm。 Step 3: Mix the above mixed solution with 250mL of palm oil at a temperature of 41.5°C, wherein the palm oil includes 2.5% Span-80 by mass percentage, and stir at a stirring speed of 1500 rpm until the temperature drops to 25 Stirring was continued for 30 minutes at a temperature of 0° C., at which point a Lactobacillus casei hydrogel micro-core emulsion was obtained, and the average particle diameter of the micro-core was 53.8 μm.
步骤4:进一步将步骤3形成的上述350mL微芯乳液与1050mL碳酸钙、海藻酸钠和卡拉胶溶液混合均匀(海藻酸钠与卡拉胶质量比为20:3、合计质量百分比浓度为3%,碳酸钙质量百分比含量为2%,温度为23℃),并挤出到温度为10℃的2.5%氯化钙溶液中,形成粒径约3mm的固化多芯微胶囊(图1,C)。 Step 4: further mix the above-mentioned 350mL microcore emulsion formed in step 3 with 1050mL calcium carbonate, sodium alginate and carrageenan solution (the mass ratio of sodium alginate to carrageenan is 20:3, and the total mass percentage concentration is 3%, The mass percentage of calcium carbonate is 2%, the temperature is 23 °C), and extruded into a 2.5% calcium chloride solution at a temperature of 10 °C to form solidified multi-core microcapsules with a particle size of about 3 mm (Figure 1, C).
该微胶囊无粘连、成球性好、表面圆整,干酪乳杆菌菌数为1×1010cfu/mL,该微胶囊在85℃下加热处理3分钟,剩余活菌数为3.2×109cfu/mL;在25℃下密封储存60天,剩余活菌数为5.6×109cfu/mL;在人工模拟胃液下4小时,干酪乳杆菌释放量为16.3%,人工模拟肠液下4小时,干酪乳杆菌释放量为94.3%。 The microcapsules have no adhesion, good spheroidity, rounded surface, the number of Lactobacillus casei is 1×10 10 cfu/mL, the microcapsules are heat-treated at 85°C for 3 minutes, and the number of remaining viable bacteria is 3.2×10 9 cfu/mL; sealed storage at 25°C for 60 days, the number of remaining viable bacteria is 5.6×10 9 cfu/mL; 4 hours under artificial simulated gastric juice, the release of Lactobacillus casei is 16.3%, 4 hours under artificial simulated intestinal juice, The release rate of Lactobacillus casei was 94.3%.
实施例4Example 4
步骤1:将1g卡拉胶悬浮于100mL蒸馏水中,加热溶解后0.4g葡萄糖和0.2g酵母抽提物和1.8g乳酸,以氢氧化钠调节pH为4.0,并冷却到40℃。 Step 1: Suspend 1 g of carrageenan in 100 mL of distilled water, heat to dissolve 0.4 g of glucose, 0.2 g of yeast extract and 1.8 g of lactic acid, adjust the pH to 4.0 with sodium hydroxide, and cool to 40°C.
步骤2:然后在步骤1形成的溶液中加入干酪乳杆菌菌泥或干酪乳杆菌固态发酵物料,并混合均匀(混合液中干酪乳杆菌浓度为7.8×1011cfu/mL)。 Step 2: Then add Lactobacillus casei sludge or Lactobacillus casei solid-state fermentation material to the solution formed in Step 1, and mix evenly (the concentration of Lactobacillus casei in the mixed solution is 7.8×10 11 cfu/mL).
步骤3:将上述混合溶液与150mL温度为40℃的棕榈油混合,其中棕榈油中包括质量百分比含量为4%的斯潘-80,并在2000转/分钟搅拌速度下搅拌至温度下降到25℃时停止搅拌,此时即获得干酪乳杆菌水凝胶微芯乳液,微芯的平均粒径为34.2μm。 Step 3: Mix the above mixed solution with 150mL of palm oil at a temperature of 40°C, wherein the palm oil includes 4% Span-80 by mass percentage, and stir at a stirring speed of 2000 rpm until the temperature drops to 25 Stirring was stopped at ℃, and the Lactobacillus casei hydrogel micro-core emulsion was obtained at this moment, and the average particle diameter of the micro-core was 34.2 μm.
步骤4:进一步将步骤3形成的上述250mL微芯乳液与500mL碳酸钙、海藻酸钠和黄原胶溶液混合均匀(海藻酸钠与黄原胶质量比为20:3、合计质量百分比浓度为2%,碳酸钙质量百分比含量为2.5%),并挤出到温度为20℃的2%氯化钙溶液中,形成粒径约2mm的固化多芯微胶囊(图1,D)。 Step 4: Further mix the above-mentioned 250mL microcore emulsion formed in step 3 with 500mL calcium carbonate, sodium alginate and xanthan gum solution (the mass ratio of sodium alginate to xanthan gum is 20:3, and the total mass percentage concentration is 2 %, the mass percentage of calcium carbonate is 2.5%), and extruded into a 2% calcium chloride solution at a temperature of 20 °C to form solidified multi-core microcapsules with a particle size of about 2 mm (Fig. 1, D).
该微胶囊无粘连、成球性好、表面圆整,干酪乳杆菌菌数为1×1011cfu/mL,该微胶囊在85℃下加热处理3分钟,剩余活菌数为4.1×1010cfu/mL;在25℃下密封储存60天,剩余活菌数为7.2×1010cfu/mL;在人工模拟胃液下4小时,干酪乳杆菌释放量为14.7%,人工模拟肠液下4小时,干酪乳杆菌释放量为95.9%。 The microcapsules have no adhesion, good spheroidity, rounded surface, and the number of Lactobacillus casei is 1×10 11 cfu/mL. The microcapsules are heat-treated at 85°C for 3 minutes, and the number of remaining viable bacteria is 4.1×10 10 cfu/mL; sealed storage at 25°C for 60 days, the number of remaining viable bacteria is 7.2×10 10 cfu/mL; 4 hours under artificial simulated gastric juice, the release of Lactobacillus casei is 14.7%, 4 hours under artificial simulated intestinal juice, The release rate of Lactobacillus casei was 95.9%.
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310626099.1A CN103652891B (en) | 2013-11-28 | 2013-11-28 | Lactobacillus casei embedding microcapsule and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310626099.1A CN103652891B (en) | 2013-11-28 | 2013-11-28 | Lactobacillus casei embedding microcapsule and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103652891A true CN103652891A (en) | 2014-03-26 |
CN103652891B CN103652891B (en) | 2015-04-08 |
Family
ID=50292610
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310626099.1A Expired - Fee Related CN103652891B (en) | 2013-11-28 | 2013-11-28 | Lactobacillus casei embedding microcapsule and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103652891B (en) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104957254A (en) * | 2015-06-08 | 2015-10-07 | 内蒙古蒙牛乳业(集团)股份有限公司 | Probiotics gel particle, preparation method thereof and dairy containing probiotics gel particle |
CN105595359A (en) * | 2016-01-29 | 2016-05-25 | 江苏微康生物科技有限公司 | Positioning and controlled-release microcapsule probiotics and preparation method thereof |
CN106222158A (en) * | 2016-05-30 | 2016-12-14 | 浙江工商大学 | A kind of microcapsule preparation method embedding lactobacillus |
CN108851155A (en) * | 2018-07-11 | 2018-11-23 | 天添爱(青岛)生物科技有限公司 | A kind of technique extending the diatery supplement nutrient supplement shelf-life |
CN110771898A (en) * | 2019-11-08 | 2020-02-11 | 厦门九和良方医药科技有限公司 | Probiotic microcapsule, preparation method and application thereof |
CN111134333A (en) * | 2018-11-06 | 2020-05-12 | 内蒙古蒙牛乳业(集团)股份有限公司 | Food or health product containing probiotic microcapsules and preparation method thereof |
CN111134332A (en) * | 2018-11-06 | 2020-05-12 | 内蒙古蒙牛乳业(集团)股份有限公司 | Method for preparing probiotic microcapsules by fluidized bed spray granulation method and product thereof |
CN111134331A (en) * | 2018-11-06 | 2020-05-12 | 内蒙古蒙牛乳业(集团)股份有限公司 | Probiotic microcapsule and preparation method thereof |
CN111134330A (en) * | 2018-11-06 | 2020-05-12 | 内蒙古蒙牛乳业(集团)股份有限公司 | Method for preparing probiotic microcapsules by extrusion granulation method and product thereof |
CN113440467A (en) * | 2021-06-02 | 2021-09-28 | 东阿阿胶股份有限公司 | Repairing and moistening hydrogel microcapsule containing donkey-hide gelatin as well as preparation method and application of repairing and moistening hydrogel microcapsule |
CN113925169A (en) * | 2021-11-23 | 2022-01-14 | 天津小薇生物科技有限公司 | Gout-relieving probiotic composition, preparation method and application thereof |
CN117210382A (en) * | 2023-11-09 | 2023-12-12 | 内蒙古蒙牛乳业(集团)股份有限公司 | Multilayer probiotic embedded particles and preparation method and application thereof |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1916161A (en) * | 2006-09-08 | 2007-02-21 | 肖雯娟 | Embedding protection method for beneficial bacteria of intestinal tract |
CN101683604A (en) * | 2009-08-21 | 2010-03-31 | 黑龙江大学 | Method for preparing lactobacillus microcapsules |
CN102595938A (en) * | 2009-07-09 | 2012-07-18 | 德戈玛益生菌有限公司 | Heat resistant probiotic compositions and healthy food comprising them |
CN102960598A (en) * | 2012-11-19 | 2013-03-13 | 陕西科技大学 | Method for preparing three-layer embedded bifidobacterium microcapsules |
CN103180432A (en) * | 2010-08-26 | 2013-06-26 | 梅西大学 | Method for preparing shelf-stable probiotic food |
CN103282028A (en) * | 2010-08-10 | 2013-09-04 | R·P·舍勒科技有限责任公司 | Process of manufacturing a stable softgel capsule containing microencapsulated probiotic bacteria |
-
2013
- 2013-11-28 CN CN201310626099.1A patent/CN103652891B/en not_active Expired - Fee Related
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1916161A (en) * | 2006-09-08 | 2007-02-21 | 肖雯娟 | Embedding protection method for beneficial bacteria of intestinal tract |
CN102595938A (en) * | 2009-07-09 | 2012-07-18 | 德戈玛益生菌有限公司 | Heat resistant probiotic compositions and healthy food comprising them |
CN101683604A (en) * | 2009-08-21 | 2010-03-31 | 黑龙江大学 | Method for preparing lactobacillus microcapsules |
CN103282028A (en) * | 2010-08-10 | 2013-09-04 | R·P·舍勒科技有限责任公司 | Process of manufacturing a stable softgel capsule containing microencapsulated probiotic bacteria |
CN103180432A (en) * | 2010-08-26 | 2013-06-26 | 梅西大学 | Method for preparing shelf-stable probiotic food |
CN102960598A (en) * | 2012-11-19 | 2013-03-13 | 陕西科技大学 | Method for preparing three-layer embedded bifidobacterium microcapsules |
Non-Patent Citations (1)
Title |
---|
宋心远 等: "《新型染整技术》", 30 November 1999, article "微胶囊", pages: 131 * |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104957254A (en) * | 2015-06-08 | 2015-10-07 | 内蒙古蒙牛乳业(集团)股份有限公司 | Probiotics gel particle, preparation method thereof and dairy containing probiotics gel particle |
CN104957254B (en) * | 2015-06-08 | 2018-10-16 | 内蒙古蒙牛乳业(集团)股份有限公司 | Probiotic gel particle, preparation method and the dairy products containing it |
CN105595359A (en) * | 2016-01-29 | 2016-05-25 | 江苏微康生物科技有限公司 | Positioning and controlled-release microcapsule probiotics and preparation method thereof |
CN106222158A (en) * | 2016-05-30 | 2016-12-14 | 浙江工商大学 | A kind of microcapsule preparation method embedding lactobacillus |
CN106222158B (en) * | 2016-05-30 | 2021-06-15 | 浙江工商大学 | A kind of microcapsule preparation method of embedding lactobacillus |
CN108851155A (en) * | 2018-07-11 | 2018-11-23 | 天添爱(青岛)生物科技有限公司 | A kind of technique extending the diatery supplement nutrient supplement shelf-life |
CN111134331A (en) * | 2018-11-06 | 2020-05-12 | 内蒙古蒙牛乳业(集团)股份有限公司 | Probiotic microcapsule and preparation method thereof |
CN111134332A (en) * | 2018-11-06 | 2020-05-12 | 内蒙古蒙牛乳业(集团)股份有限公司 | Method for preparing probiotic microcapsules by fluidized bed spray granulation method and product thereof |
CN111134333A (en) * | 2018-11-06 | 2020-05-12 | 内蒙古蒙牛乳业(集团)股份有限公司 | Food or health product containing probiotic microcapsules and preparation method thereof |
CN111134330A (en) * | 2018-11-06 | 2020-05-12 | 内蒙古蒙牛乳业(集团)股份有限公司 | Method for preparing probiotic microcapsules by extrusion granulation method and product thereof |
CN111134334A (en) * | 2018-11-06 | 2020-05-12 | 内蒙古蒙牛乳业(集团)股份有限公司 | Probiotic microcapsule soft particles and preparation method thereof |
CN111134334B (en) * | 2018-11-06 | 2023-08-29 | 内蒙古蒙牛乳业(集团)股份有限公司 | A kind of probiotic microcapsule soft granule and its preparation method |
CN110771898A (en) * | 2019-11-08 | 2020-02-11 | 厦门九和良方医药科技有限公司 | Probiotic microcapsule, preparation method and application thereof |
CN113440467A (en) * | 2021-06-02 | 2021-09-28 | 东阿阿胶股份有限公司 | Repairing and moistening hydrogel microcapsule containing donkey-hide gelatin as well as preparation method and application of repairing and moistening hydrogel microcapsule |
CN113440467B (en) * | 2021-06-02 | 2022-07-05 | 东阿阿胶股份有限公司 | Repairing and moistening hydrogel microcapsule containing donkey-hide gelatin as well as preparation method and application of repairing and moistening hydrogel microcapsule |
CN113925169A (en) * | 2021-11-23 | 2022-01-14 | 天津小薇生物科技有限公司 | Gout-relieving probiotic composition, preparation method and application thereof |
CN117210382A (en) * | 2023-11-09 | 2023-12-12 | 内蒙古蒙牛乳业(集团)股份有限公司 | Multilayer probiotic embedded particles and preparation method and application thereof |
CN117210382B (en) * | 2023-11-09 | 2024-01-30 | 内蒙古蒙牛乳业(集团)股份有限公司 | Multilayer probiotic embedded particles and preparation method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN103652891B (en) | 2015-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103652891B (en) | Lactobacillus casei embedding microcapsule and preparation method thereof | |
Shi et al. | Encapsulation of probiotic Lactobacillus bulgaricus in alginate–milk microspheres and evaluation of the survival in simulated gastrointestinal conditions | |
Shi et al. | Encapsulation of Lactobacillus bulgaricus in carrageenan-locust bean gum coated milk microspheres with double layer structure | |
JP6081374B2 (en) | Protection of microbial cells from acid degradation | |
Silva et al. | Symbiotic microencapsulation to enhance Lactobacillus acidophilus survival | |
Rosas‐Ledesma et al. | Calcium alginate capsules for oral administration of fish probiotic bacteria: assessment of optimal conditions for encapsulation | |
Li et al. | Construction of multilayer alginate hydrogel beads for oral delivery of probiotics cells | |
CN105310080B (en) | Probiotic microcapsules and its preparation method and application | |
Islam et al. | Microencapsulation of live probiotic bacteria | |
CN104435283B (en) | A kind of probiotic microcapsule and preparation method added with prebiotics | |
CN103932186B (en) | A kind of bifidus longum bb microcapsule and preparation method thereof | |
CN107260704B (en) | Enterococcus faecalis microcapsule and preparation method thereof | |
CN101289648B (en) | Enterococcus faecium microcapsule formulation and method for preparing same | |
Lai et al. | Microencapsulation of Lactobacillus rhamnosus GG with flaxseed mucilage using co-extrusion technique | |
Vivek | Use of encapsulated probiotics in dairy based foods | |
Mandal et al. | Enhancement of survival of alginate‐encapsulated Lactobacillus casei NCDC 298 | |
CN112956698A (en) | Probiotics microcapsule embedded blasting bead and preparation method thereof | |
CN106617093B (en) | Acid-resistant and stable probiotic microcapsule and preparation method and application thereof | |
CN104388416A (en) | Preparation method of microporous starch embedded lactic acid bacteria | |
CN109007807A (en) | A kind of microcapsules fruit ferment powder and preparation method thereof | |
CN113040174A (en) | Microcapsule microbial inoculum and preparation method and application thereof | |
Panghal et al. | Microencapsulation for delivery of probiotic bacteria | |
CN112335884A (en) | Novel probiotic microsphere and preparation method thereof | |
Krasaekoopt | Microencapsulation of probiotics in hydrocolloid gel matrices: a review | |
Li et al. | Preparation and property of layer-by-layer alginate hydrogel beads based on multi-phase emulsion technique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150408 Termination date: 20211128 |